PL1989323T3 - Sposoby diagnostyki z oznaczaniem liczby kopii genów i SNP w klastrze genów FcRII/FcRIII oraz sondy do zastosowania w takich sposobach do wykrywania podatności na choroby autoimmunologiczne i skuteczności ich leczenia - Google Patents

Sposoby diagnostyki z oznaczaniem liczby kopii genów i SNP w klastrze genów FcRII/FcRIII oraz sondy do zastosowania w takich sposobach do wykrywania podatności na choroby autoimmunologiczne i skuteczności ich leczenia

Info

Publication number
PL1989323T3
PL1989323T3 PL06835684T PL06835684T PL1989323T3 PL 1989323 T3 PL1989323 T3 PL 1989323T3 PL 06835684 T PL06835684 T PL 06835684T PL 06835684 T PL06835684 T PL 06835684T PL 1989323 T3 PL1989323 T3 PL 1989323T3
Authority
PL
Poland
Prior art keywords
amount
subject
rii
snps
probes
Prior art date
Application number
PL06835684T
Other languages
English (en)
Inventor
Dirk Roos
Taco Willem Kuijpers
Original Assignee
Stichting Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Sanquin Bloedvoorziening filed Critical Stichting Sanquin Bloedvoorziening
Publication of PL1989323T3 publication Critical patent/PL1989323T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL06835684T 2005-12-22 2006-12-22 Sposoby diagnostyki z oznaczaniem liczby kopii genów i SNP w klastrze genów FcRII/FcRIII oraz sondy do zastosowania w takich sposobach do wykrywania podatności na choroby autoimmunologiczne i skuteczności ich leczenia PL1989323T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05077984A EP1801234A1 (en) 2005-12-22 2005-12-22 Diagnostic methods involving determining gene copy numbers and use thereof
EP06835684A EP1989323B1 (en) 2005-12-22 2006-12-22 DIAGNOSTIC METHODS INVOLVING DETERMINING GENE COPY NUMBERS AND SNPs IN THE Fc RII/Fc RIII GENE CLUSTER, AND PROBES FOR USE IN SUCH METHODS TO DETECT SUSCEPTIBILITY TO AND TREATMENT EFFICACY IN AUTOIMMUNE DISEASES
PCT/NL2006/000662 WO2007073179A2 (en) 2005-12-22 2006-12-22 DIAGNOSTIC METHODS INVOLVING DETERMINING GENE COPY NUMBERS AND SNPs IN THE FcϜRII/FcϜRIII GENE CLUSTER, AND PROBES FOR USE IN SUCH METHODS TO DETECT SUSCEPTIBILITY TO AND TREATMENT EFFICACY IN AUTOIMMUNE DISEASES

Publications (1)

Publication Number Publication Date
PL1989323T3 true PL1989323T3 (pl) 2011-12-30

Family

ID=35953866

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06835684T PL1989323T3 (pl) 2005-12-22 2006-12-22 Sposoby diagnostyki z oznaczaniem liczby kopii genów i SNP w klastrze genów FcRII/FcRIII oraz sondy do zastosowania w takich sposobach do wykrywania podatności na choroby autoimmunologiczne i skuteczności ich leczenia

Country Status (10)

Country Link
US (2) US7994300B2 (pl)
EP (2) EP1801234A1 (pl)
AT (1) ATE515580T1 (pl)
AU (1) AU2006327982A1 (pl)
CA (1) CA2634692A1 (pl)
DK (1) DK1989323T3 (pl)
ES (1) ES2369415T3 (pl)
PL (1) PL1989323T3 (pl)
PT (1) PT1989323E (pl)
WO (1) WO2007073179A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9157118B2 (en) 2007-10-09 2015-10-13 Arkray, Inc. Probes for detecting immune-related gene polymorphisms and applications of the same
EP2055790A1 (en) * 2007-10-30 2009-05-06 Leibniz-Institut für Altersforschung - Fritz-Lipmann-Institut e.V. Calibration molecule and method for determining the number of copies of genes/target loci in a genome using said calibration molecule
US20120030144A1 (en) * 2007-11-08 2012-02-02 Pikamab, Inc. Methods for doing business using biomarkers
US20100330568A1 (en) * 2008-01-09 2010-12-30 Stefan Meuer Assay and method for the assessment of responders and non-responders to nk cell modulation by immunoglobulin therapy
US20110268753A1 (en) * 2009-01-08 2011-11-03 The Uab Research Foundation Process for regulating immune response
CN102959088A (zh) * 2010-02-02 2013-03-06 艾博特生物技术有限公司 用于预测对TNF-α抑制剂治疗的反应性的方法和组合物
US20140336950A1 (en) * 2011-11-16 2014-11-13 Univerisity of South Dakota Clustering copy-number values for segments of genomic data
CN118222709A (zh) * 2024-03-25 2024-06-21 南京医科大学 FcγRIIA作为胶质瘤生物标志物和治疗靶点的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830652A (en) * 1994-08-30 1998-11-03 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Method for determining predisposition to severe forms of autoimmune disease by determining Fcy receptor allelic patterns
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
EP1511690A4 (en) * 2002-05-16 2007-10-24 Univ Vanderbilt TECHNIQUE FOR PREDICTING AUTOIMMUNE DISEASES
US7425620B2 (en) * 2002-08-14 2008-09-16 Scott Koenig FcγRIIB-specific antibodies and methods of use thereof
US20080248465A1 (en) 2004-04-26 2008-10-09 Uab Research Foundation Polymorphisms in the Fcgr2b Promoter and Uses Thereof

Also Published As

Publication number Publication date
CA2634692A1 (en) 2007-06-28
EP1989323A2 (en) 2008-11-12
ES2369415T3 (es) 2011-11-30
AU2006327982A8 (en) 2008-07-24
US20110189672A1 (en) 2011-08-04
ATE515580T1 (de) 2011-07-15
WO2007073179A3 (en) 2008-01-17
PT1989323E (pt) 2011-09-29
US7994300B2 (en) 2011-08-09
EP1989323B1 (en) 2011-07-06
EP1801234A1 (en) 2007-06-27
AU2006327982A1 (en) 2007-06-28
US8765372B2 (en) 2014-07-01
DK1989323T3 (da) 2011-09-26
US20090263795A1 (en) 2009-10-22
WO2007073179A2 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
PT1989323E (pt) Métodos de diagnóstico envolvendo a determinação do número de cópias de genes e snps no grupo de genes fcrii/fcriii e sondas para usar em tais métodos para detecção da susceptibilidade a doenças auto-imunes e eficácia do correspondent
AU2017339858B2 (en) Improved methods of assessing GFAP status in patient samples
JP7277623B2 (ja) 生体試料中で改善された性能を有するｉｇｆｂｐ７のためのアッセイ
Lowe et al. Significant IgG subclass heterogeneity in HLA-specific antibodies: implications for pathogenicity, prognosis, and the rejection response
JP5709341B2 (ja) 個体の再構成又は標的遺伝的組換えの定量的評価の方法及びその使用
JP7054990B2 (ja) 炎症性腸疾患の診断及び治療のための方法
CA2778810C (en) Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
JP2015535820A5 (pl)
CN103608038A (zh) 施用β7整联蛋白拮抗剂的方法
MX2015003932A (es) Metodos para diagnosticar y tratar la enfermedad inflamatoria intestinal.
WO2007009469A2 (en) Potency assays for antibody drug substance binding to an fc receptor
Kawa The immunobiology of immunoglobulin G4 and complement activation pathways in IgG4-related disease
CN112469434A (zh) 抗pla2-gib抗体及其用途
US20070231813A1 (en) Fcgr3a Gebotype and Methods for Evaluating Treatment Response to Non-Depleting Antibodies
SG187787A1 (en) Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
JP2022528804A (ja) 抗体力価試験
JP2008500832A (ja) Ｆｃｇｒ３ａゲボタイプ（ｇｅｂｏｔｙｐｅ）および非枯渇性抗体に対する処置応答を評価するための方法
CN109963865A (zh) 用于检测和治疗肥大细胞活性相关病症的生物标记
KR20130108324A (ko) 대장직장암 마커에 대한 항체
Aoyama et al. A cell-based reporter assay measuring the activation of fc gamma receptors induced by therapeutic monoclonal antibodies
JPWO2009133951A1 (ja) 抗汗抗原モノクローナル抗体
Sethi et al. VH1 family immunoglobulin repertoire sequencing after allogeneic hematopoietic stem cell transplantation
CA2440960A1 (en) An early pre-symptomatic prion diagnostic blood test for encephalopathies
JP2023553890A (ja) 疾患関連タンパク質組成物を産生するためのシステム及び方法
Li et al. Selection of potential cytokeratin-18 monoclonal antibodies following IGH repertoire evaluation in mice